| Risk of adverse outcomes in patients treated with catheter ablation | Class | References |
|---|---|---|
| Patients that undergo an AF ablation should be monitored closely in the first 30 days after the procedure due to a higher risk of neurological, gastrointestinal, cardiovascular, vascular and peripheral complications. |  | 319–324 |
| Wolff–Parkinson–White syndrome patients following radiofrequency ablation may benefit from additional follow-up due to a persistent elevated risk of developing AF compared to the general population. |  | 295,325 |
| Risk of adverse outcomes in patients treated with catheter ablation | Class | References |
|---|---|---|
| Patients that undergo an AF ablation should be monitored closely in the first 30 days after the procedure due to a higher risk of neurological, gastrointestinal, cardiovascular, vascular and peripheral complications. | | 319–324 |
| Wolff–Parkinson–White syndrome patients following radiofrequency ablation may benefit from additional follow-up due to a persistent elevated risk of developing AF compared to the general population. | | 295,325 |
| Risk of adverse outcomes in patients treated with catheter ablation | Class | References |
|---|---|---|
| Patients that undergo an AF ablation should be monitored closely in the first 30 days after the procedure due to a higher risk of neurological, gastrointestinal, cardiovascular, vascular and peripheral complications. | | 319–324 |
| Wolff–Parkinson–White syndrome patients following radiofrequency ablation may benefit from additional follow-up due to a persistent elevated risk of developing AF compared to the general population. | | 295,325 |
| Risk of adverse outcomes in patients treated with catheter ablation | Class | References |
|---|---|---|
| Patients that undergo an AF ablation should be monitored closely in the first 30 days after the procedure due to a higher risk of neurological, gastrointestinal, cardiovascular, vascular and peripheral complications. | | 319–324 |
| Wolff–Parkinson–White syndrome patients following radiofrequency ablation may benefit from additional follow-up due to a persistent elevated risk of developing AF compared to the general population. | | 295,325 |
